Items Per Page 102550 Year All2024202320222021202020192018201720162015201420132012201120102009 August 28, 2024 Delcath Systems to Participate at the H.C. Wainwright 26th Annual Global Investment Conference PDF Version August 28, 2024 Delcath Systems, Inc. Announces Positive Results from Independent Study on Liver-Directed Therapy for Uveal Melanoma Patients PDF Version August 27, 2024 Delcath Systems, Inc. Announces Positive Outcomes from Independent Study on Hepatic Perfusion for Uveal Melanoma Patients PDF Version August 26, 2024 Delcath Systems, Inc. Announces Promising Results from Independent Study on Repeated Hepatic Chemosaturation for Liver Tumors PDF Version August 20, 2024 Delcath Systems Announces Poster Presentation at the 2024 ESMO Congress PDF Version August 12, 2024 Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PDF Version August 5, 2024 Delcath Systems Reports Second Quarter 2024 Results and Business Highlights PDF Version August 5, 2024 Delcath Systems Announces CMS Approval for NTAP for HEPZATO KIT™ PDF Version July 30, 2024 Delcath Systems to Participate in Upcoming Investor Conferences PDF Version July 22, 2024 Delcath Systems to Host Second Quarter 2024 Earnings Call PDF Version
August 28, 2024 Delcath Systems to Participate at the H.C. Wainwright 26th Annual Global Investment Conference PDF Version
August 28, 2024 Delcath Systems, Inc. Announces Positive Results from Independent Study on Liver-Directed Therapy for Uveal Melanoma Patients PDF Version
August 27, 2024 Delcath Systems, Inc. Announces Positive Outcomes from Independent Study on Hepatic Perfusion for Uveal Melanoma Patients PDF Version
August 26, 2024 Delcath Systems, Inc. Announces Promising Results from Independent Study on Repeated Hepatic Chemosaturation for Liver Tumors PDF Version
August 5, 2024 Delcath Systems Reports Second Quarter 2024 Results and Business Highlights PDF Version
